Citations

Showing 10 of 108152 citations.

Urinary Retention Following Inguinal Herniorrhaphy: Role of Neuromuscular Blockade Reversal
Morales, Diana J. Valencia , Stewart, Brody R., Heller, Stephanie F. , Schroeder, D. R., Schroeder, Darrell R. , Schroeder, Darrel R, Valencia Morales, Diana J , Schroeder, Darrell , Šprung, Juraj , Ghanem, Omar M. , Weingarten, Toby N.

Mayo Clinic

Surgical Laparoscopy, Endoscopy & Percutaneous Techniques | May 24, 2021 | Volume: 31 | Issue: 5 | Pages: 613-617

10.1097/sle.0000000000000962 | PMID 34288639 Get It

Background: Nondepolarizing neuromuscular blockade is reversed with neostigmine/glycopyrrolate or sugammadex. Anticholinergic glycopyrrolate decreases bladder detrusor muscle contractility, potentially leading to postoperative urinary retention (POUR). POUR commonly complicates inguinal herniorrhaphy. In this study we assess association between reversal technique and POUR. Methods: Records of adult patients undergoing unilateral inguinal herniorrhaphy with neuromuscular blockade from January 2013 to September 2020 were reviewed for POUR (unplanned postoperative insertion of urinary catheter). A propensity-adjusted analysis was performed to assess POUR in neostigmine/glycopyrrolate versus sugammadex using inverse probability of treatment weighting (IPTW) to adjust for potential confounding. Results: We identified 181 patients who underwent herniorrhaphy with amnio-steroidal neuromuscular blockers, 75 (41.4%) who received sugammadex and 106 (58.6%) neostigmine/glycopyrrolate. Compared with sugammadex, neostigmine/glycopyrrolate group had longer surgical course [unweighted standardized difference (USTD)=0.38, P=0.004], received more intraoperative opioids (USTD=0.704, P<0.001), more often performed via laparoscopic approach (USTD=0.407, P=0.012), and less often with periprocedural urinary catheter insertion (USTD=0.452, P=0.003). POUR was observed in 2 (3%) of patients in the sugammadex group, and 16 (15%) in neostigmine/glycopyrrolate [unadjusted odds ratio (OR)=0.15; 95% confidence interval (CI): 0.03-0.69; P=0.015, and IPTW OR=0.13; 95% CI: 0.03-0.64; P=0.012]. Results remained similar with further analysis adjusted for opioid administration in the postanesthesia care unit (adjusted IPTW OR=0.18; 95% CI: 0.04-0.88; P=0.034). Of the POUR patients, 9 required unplanned overnight admission and 4 emergency room visit. Conclusion: These results suggest that neuromuscular blockade reversal with sugammadex is associated with lower rates of POUR following unilateral inguinal herniorrhaphy. Our results need to be reconfirmed in a randomized prospective study.
Gradient changes in bioprosthetic valve thrombosis: duration of anticoagulation and strategies to improve detection
Naser, Jwan A. , Petrescu, Ioana, Ionescu, Filip , Pellikka, Patricia A. , Connolly, Heidi M. , Egbe, Alexander C. , Pellikka, Patricia A , Naser, Jwan A , Nkomo, Vuyisile T. , Pislaru, Cristina , Schaff, Hartzell V. , Pislaru, Sorin V.

Mayo Clinic

Open Heart | May 24, 2021 | Volume: 8 | Issue: 1 | Pages: e001608

10.1136/openhrt-2021-001608 | PMID 34031215 Get It

Objective Bioprosthetic valve thrombosis (BPVT) is increasingly recognised as a major cause of prosthetic dysfunction in the first years postimplantation. How early abnormal gradients can be detected prior to diagnosis and how fast they normalise with anticoagulant therapy is unknown. We set forth to (1) evaluate patterns of increase in gradients prior to BPVT diagnosis and (2) characterise time-course of response to anticoagulation. Methods Patients treated with warfarin for BPVT (1999–2019) with clinically significant reduction of mean gradients (≥25%) were identified retrospectively. Recovery was defined as gradient decrease ≥50%, to postimplantation or to normal-range gradients per position, model and size. Time-to-BPVT (implantation—BPVT diagnosis), potential diagnostic delay (first abnormal gradient by position, model and size—BPVT diagnosis) and time-to-recovery (BPVT diagnosis—complete resolution) were recorded. Results 77 patients were identified; 32 (42%) aortic (23 surgical—12 porcine, 11 pericardial; 9 transcatheter); 24 (31%) mitral; 21 (27%) tricuspid. Median time-to-BPVT was 24, 21 and 10 months, respectively. Potential diagnostic delay was median 21 months for aortic, 4 months for mitral, but 0 for tricuspid. Recovery was significantly faster in mitral than aortic (median 2.5 vs 4.8 months, p=0.038) and tricuspid (median 5.9 months, p=0.025) positions. Porcine aortic valves responded faster than pericardial aortic valves (median 2.9 vs 20.3 months, p=0.004). Conclusion Gradients start to increase months before the clinical BPVT diagnosis. Recovery is faster in mitral and surgical aortic porcine valves; a longer warfarin trial seems indicated in tricuspid and surgical aortic pericardial valves.
How We Did It: Virtual Interviews With an Eye Toward the Future
Kamboj, Amrit K. , Simonetto, Douglas A. , Raffals, Laura E. , Simonetto, Douglas A , Chandrasekhara, Vinay

Mayo Clinic

American Journal of Gastroenterology | May 24, 2021 | Volume: 116 | Issue: 10 | Pages: 1972-1975

10.14309/ajg.0000000000001314 | PMID 34028364 Get It

Body Mass Index, Multi-Morbidity, and COVID-19 Risk Factors as Predictors of Severe COVID-19 Outcomes
Nanda, S. , Chacin‐Suarez, Audry , Toussaint, Loren , Vincent, Ann, Schroeder, Darrell R. , Medina‐Inojosa, José R. , DeJesus, Ramona S. , Lebdeh, Haitham S. Abu, Iftikhar, Salma , Croghan, Ivana T. , Chacin Suarez, Audry S, Hurt, Ryan, Medina Inojosa, Jose R, O'Horo, John C, Abu Lebdeh, Haitham S, Croghan, Ivana T , Toussaint, Loren L , Medina-Inojosa, José R , Schroeder, Darrell , Fischer, Karen M. , Hurt, Ryan T. , O’Horo, John C. , Mundi, Manpreet S. , Chacin Suarez, Audry S

Mayo Clinic

Journal of Primary Care & Community Health | May 24, 2021 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/21501327211018559 | PMID 34024181 Get It

Purpose The purpose of the present study was to investigate body mass index, multi-morbidity, and COVID-19 Risk Score as predictors of severe COVID-19 outcomes. Patients Patients from this study are from a well-characterized patient cohort collected at Mayo Clinic between January 1, 2020 and May 23, 2020; with confirmed COVID-19 diagnosis defined as a positive result on reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assays from nasopharyngeal swab specimens. Measures Demographic and clinical data were extracted from the electronic medical record. The data included: date of birth, gender, ethnicity, race, marital status, medications (active COVID-19 agents), weight and height (from which the Body Mass Index (BMI) was calculated, history of smoking, and comorbid conditions to calculate the Charlson Comorbidity Index (CCI) and the U.S Department of Health and Human Services (DHHS) multi-morbidity score. An additional COVID-19 Risk Score was also included. Outcomes included hospital admission, ICU admission, and death. Results Cox proportional hazards models were used to determine the impact on mortality or hospital admission. Age, sex, and race (white/Latino, white/non-Latino, other, did not disclose) were adjusted for in the model. Patients with higher COVID-19 Risk Scores had a significantly higher likelihood of being at least admitted to the hospital (HR = 1.80; 95% CI = 1.30, 2.50; P < .001), or experiencing death or inpatient admission (includes ICU admissions) (HR = 1.20; 95% CI = 1.02, 1.42; P = .028). Age was the only statistically significant demographic predictor, but obesity was not a significant predictor of any of the outcomes. Conclusion Age and COVID-19 Risk Scores were significant predictors of severe COVID-19 outcomes. Further work should examine the properties of the COVID-19 Risk Factors Scale.
High-resolution MRI of a peroneal intraneural ganglion cyst arising from the knee joint: illustrative case
Jack, Megan M. , Powell, Garret M. , Frick, Matthew A., Amrami, Kimberly K. , Spinner, Robert J. , Smith, Brandon W.

Mayo Clinic

Journal of Neurosurgery: Case Lessons | May 24, 2021 | Volume: 1 | Issue: 21 | Pages: No page available

10.3171/case21130 | PMID 35854869 Get It

BACKGROUND The advancement of high-resolution imaging and increased clinical experience have led to an increased understanding of the formation and treatment of intraneural ganglion cysts. Nearly all intraneural ganglion cysts in the common peroneal nerve have been reported to arise from a joint connection to the superior tibiofibular joint. The authors have identified four cases of intraneural ganglion cysts arising from the knee joint itself; however, none of these reported cases were well described, documented, or illustrated with high-resolution imaging. OBSERVATIONS Here the authors present the case of an intraneural ganglion cyst arising from the knee joint and causing intermittent weakness and pain. The articular branch to the knee joint was clearly demonstrated on high-resolution magnetic resonance imaging and confirmed at surgical exploration. The patient was treated with articular branch ligation and has had complete resolution of his symptoms without recurrence of the cyst on follow-up imaging. LESSONS This case adds to the mounting evidence that intraneural cyst pathology is dependent on a connection to a synovial joint as stated in the unifying theory of intraneural cyst development.
Posterolateral Corner Repair With Internal Bracing and Peroneal Nerve Neurolysis
Jildeh, Toufic R. , Buckley, Patrick J. , Okoroha, Kelechi R. , Buckley, Patrick , Abbas, Muhammad J.

Mayo Clinic

Arthroscopy Techniques | May 24, 2021 | Volume: 10 | Issue: 6 | Pages: No page available

10.1016/j.eats.2021.03.006 | PMID 34258216 Get It

Abstract Posterolateral corner (PLC) reconstruction has been shown to be an effective treatment for PLC injuries. Acute anatomical repair of the PLC has the same potential to stabilize the knee; however, outcomes are less defined. Surgical repair minimizes graft harvest morbidity and allows for the maintenance of native tissue proprioception. Furthermore, augmentation with a flat‐braided suture (SutureTape; Arthrex) portends additional repair strength and protection. The purpose of this Technical Note and video is to provide our preferred method of PLC repair in a patient with an acute knee dislocation and injury to the biceps femoris, lateral collateral ligament, iliotibial band, popliteofibular ligament, and the meniscocapsular attachment of the lateral meniscus. Technique Video video See video under supplementary data.
Adjuvant Inhaled Corticosteroids in Community-Acquired Pneumonia: A Review Article
KUKHON, FAEQ R , Festić, Emir

Mayo Clinic

Medical Sciences | May 24, 2021 | Volume: 9 | Issue: 2 | Pages: 34

10.3390/medsci9020034 | PMID 34071031 Get It

Community-acquired pneumonia is still a major cause of morbidity and mortality worldwide. Since the inflammatory response induced by the immune system is often a major contributor to the lung injury, it becomes reasonable to assess the potential benefit of anti-inflammatory agents in treating community-acquired pneumonia. The role of corticosteroids as adjunct anti-inflammatory agents in treating community-acquired pneumonia is still controversial. Several studies have assessed the benefit of their use in patients with community-acquired pneumonia. In most of those studies, the route of corticosteroids administration was systemic. The aim of this article is to provide a concise review of the role of corticosteroids in treating community-acquired pneumonia when administered via inhalational route, with the potential benefit of avoiding systemic side effects of corticosteroids while exerting the same anti-inflammatory effects on the lungs. Conclusion: the use of inhaled corticosteroids may be of benefit in certain patient subsets with community-acquired pneumonia. Further randomized controlled trials are needed for better determination of such patient subsets.
Future Directions in Maintenance Therapy in Multiple Myeloma
Holstein, Sarah A. , Hillengaß, Jens, Suman, Vera J. , Hillengass, Jens, McCarthy, Philip L.

Mayo Clinic

Journal of Clinical Medicine | May 24, 2021 | Volume: 10 | Issue: 11 | Pages: 2261

10.3390/jcm10112261 | PMID 34073689 Get It

Autologous stem cell transplantation (ASCT) has been a backbone of therapy for newly diagnosed patients with multiple myeloma eligible for high-dose therapy for decades. Survival outcomes have continued to improve over time, in part because of the incorporation of highly effective induction regimens prior to ASCT as well as post-ASCT maintenance therapy. Randomized phase III clinical trials have helped establish lenalidomide maintenance as a standard of care. However, as nearly all patients will eventually experience disease relapse, there continues to be significant interest in developing novel maintenance strategies to improve upon lenalidomide maintenance. In this review, we summarize the available evidence for the use of immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies as post-ASCT maintenance therapies as well as discuss future directions and unanswered questions in the field.
Bro1 stimulates Vps4 to promote intralumenal vesicle formation during multivesicular body biogenesis
Tseng, Chun‐Che , Dean, Shirley, Davies, Brian A., Azmi, Ishara F. , Pashkova, Natalya , Payne, Johanna A., Staffenhagen, Jennifer, West, Matt , Piper, Robert C. , Katzmann, David J. , Katzmann, David J , Piper, Robert C , Dean, Shirley, Odorizzi, Greg

Mayo Clinic

Journal of Cell Biology | May 24, 2021 | Volume: 220 | Issue: 8 | Pages: No page available

10.1083/jcb.202102070 | PMID 34160559 Get It

Endosomal sorting complexes required for transport (ESCRT-0, -I, -II, -III) execute cargo sorting and intralumenal vesicle (ILV) formation during conversion of endosomes to multivesicular bodies (MVBs). The AAA-ATPase Vps4 regulates the ESCRT-III polymer to facilitate membrane remodeling and ILV scission during MVB biogenesis. Here, we show that the conserved V domain of ESCRT-associated protein Bro1 (the yeast homologue of mammalian proteins ALIX and HD-PTP) directly stimulates Vps4. This activity is required for MVB cargo sorting. Furthermore, the Bro1 V domain alone supports Vps4/ESCRT–driven ILV formation in vivo without efficient MVB cargo sorting. These results reveal a novel activity of the V domains of Bro1 homologues in licensing ESCRT-III–dependent ILV formation and suggest a role in coordinating cargo sorting with membrane remodeling during MVB sorting. Moreover, ubiquitin binding enhances V domain stimulation of Vps4 to promote ILV formation via the Bro1–Vps4–ESCRT-III axis, uncovering a novel role for ubiquitin during MVB biogenesis in addition to facilitating cargo recognition.
TFEB Overexpression, Not mTOR Inhibition, Ameliorates RagCS75Y Cardiomyopathy
Lu, Linghui , Dvornikov, Alexey V. , Ma, Xiao , Zhu, Ping , Kim, Maengjo , Ding, Yonghe , Olson, Timothy M. , Zhu, Ping, Lin, Xueying , Xu, Xiaolei

Mayo Clinic

International Journal of Molecular Sciences | May 23, 2021 | Volume: 22 | Issue: 11 | Pages: 5494

10.3390/ijms22115494 | PMID 34071043 Get It

A de novo missense variant in Rag GTPase protein C (RagCS75Y) was recently identified in a syndromic dilated cardiomyopathy (DCM) patient. However, its pathogenicity and the related therapeutic strategy remain unclear. We generated a zebrafish RragcS56Y (corresponding to human RagCS75Y) knock-in (KI) line via TALEN technology. The KI fish manifested cardiomyopathy-like phenotypes and poor survival. Overexpression of RagCS75Y via adenovirus infection also led to increased cell size and fetal gene reprogramming in neonatal rat ventricle cardiomyocytes (NRVCMs), indicating a conserved mechanism. Further characterization identified aberrant mammalian target of rapamycin complex 1 (mTORC1) and transcription factor EB (TFEB) signaling, as well as metabolic abnormalities including dysregulated autophagy. However, mTOR inhibition failed to ameliorate cardiac phenotypes in the RagCS75Y cardiomyopathy models, concomitant with a failure to promote TFEB nuclear translocation. This observation was at least partially explained by increased and mTOR-independent physical interaction between RagCS75Y and TFEB in the cytosol. Importantly, TFEB overexpression resulted in more nuclear TFEB and rescued cardiomyopathy phenotypes. These findings suggest that S75Y is a pathogenic gain-of-function mutation in RagC that leads to cardiomyopathy. A primary pathological step of RagCS75Y cardiomyopathy is defective mTOR–TFEB signaling, which can be corrected by TFEB overexpression, but not mTOR inhibition.